Artificial intelligence is being used to identify potential drug safety issues, including by analyzing clinical notes and online posts. Some reports suggest that ai has found previously unreported side effects, although it is unclear if this has led to improvements in patient outcomes. The use of ai in drug safety monitoring is a developing area, with applications in medical records, drug labeling, and post-market surveillance.